Detalhe da pesquisa
1.
Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge.
Alzheimers Dement
; 19(5): 1800-1820, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36284403
2.
Macroeconomic consequences of the COVID-19 pandemic.
Econ Model
; 120: 106147, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570545
3.
Access to Disease-Modifying Alzheimer's Therapies: Addressing Possible Challenges Using Innovative Payment Models.
Value Health
; 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803845
4.
Crosswalk between the Mini-Mental State Examination and the Telephone Interview for Cognitive Status (TICS-27/30/40).
Alzheimers Dement
; 18(11): 2036-2041, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103408
5.
Exploring the Impact of COVID-19 Restrictions on Nursing Home Residents', Families', and Staff's Perceptions of Bioethical Principles: A Qualitative Study.
J Appl Gerontol
; : 7334648241249626, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38742826
6.
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans.
BioDrugs
; 37(4): 531-540, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004706
7.
Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial Payers.
Pharmacoeconomics
; 40(7): 647-652, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35553029
8.
Impact of non-binding FDA guidances on primary endpoint selection in Alzheimer's disease trials.
Alzheimers Dement (N Y)
; 8(1): e12280, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35356740
9.
Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review.
J Alzheimers Dis
; 83(2): 591-608, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334392
10.
The economics of alternative payment models for pharmaceuticals.
Eur J Health Econ
; 22(4): 559-569, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725260
11.
The Potential Benefits of Deferred Payment for a Hypothetical Gene Therapy for Congestive Heart Failure: A Cost-Consequence Analysis.
Appl Health Econ Health Policy
; 18(5): 669-677, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32090302
12.
Outcome measures for oncology alternative payment models: practical considerations and recommendations.
Am J Manag Care
; 25(12): e403-e409, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860235
13.
Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment.
Rand Health Q
; 8(3): 2, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205802
14.
Biosimilar Cost Savings in the United States: Initial Experience and Future Potential.
Rand Health Q
; 7(4): 3, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30083415